Skip to main content

Advertisement

Table 4 Serum measurements

From: The effects of pre- and post-exercise consumption of multi-ingredient performance supplements on cardiovascular health and body fat in trained men after six weeks of resistance training: a stratified, randomized, double-blind study

Variable Group n Baseline Post Time Group x Time
Triglycerides MIPS 10 90.6 ± 27.1 118.5 ± 41.6 0.1124 0.571
mg/dL Placebo 7 89.3 ± 26.9 102.9 ± 47.8   
Total Cholesterol MIPS 13 150.4 ± 31.4 145.0 ± 18.6 0.9464 0.273
mg/dL Placebo 9 162.8 ± 47.5 167.6 ± 41.5   
HDL MIPS 13 44.5 ± 7.4 42.6 ± 8.2 0.3284 0.978
mg/dL Placebo 11 45.0 ± 13.2 43.1 ± 6.6   
LDL MIPS 10 89.5 ± 29.0 82.7 ± 19.4 0.9253 0.201
mg/dL Placebo 7 103.7 ± 29.7 109.5 ± 46.6   
Non-HDL MIPS 13 105.9 ± 30.0 101.2 ± 21.1 0.9725 0.249
mg/dL Placebo 9 117.8 ± 47.6 122.2 ± 43.5   
Glucose MIPS 12 94.4 ± 4.0 97.1 ± 10.1 0.2655 0.821
mg/dL Placebo 10 92.1 ± 10.4 94.0 ± 6.8   
Cortisol MIPS 13 123.4 ± 57.2 123.4 ± 65.8 0.5071 0.503
nmol/L Placebo 11 116.2 ± 37.1 98.4 ± 31.5   
Endogenous Nitrite MIPS 13 5.3 ± 1.6 5.2 ± 1.1 0.9663 0.761
(μmol/L) Placebo 11 5.3 ± 1.2 5.4 ± 1.4   
Total Nitrite MIPS 13 18.4 ± 18.5 17.9 ± 18.0 0.7688 0.957
(μmol/L) Placebo 11 20.6 ± 20.6 20.2 ± 20.2   
Nitrate MIPS 13 13.1 ± 6.5 12.7 ± 11.0 0.7782 0.978
(μmol/L) Placebo 11 15.3 ± 6.5 14.8 ± 9.1   
Nitrate/Nitrite MIPS 13 0.5 ± 0.4 0.7 ± 0.7 0.3325 0.629
  Placebo 11 0.4 ± 0.2 0.4 ± 0.3   
hs-CRP MIPS 11 1.0 ± 0.87 1.1 ± 0.97 0.1478 0.199
(mg/L) Placebo 8 0.78 ± 0.89 2.1 ± 2.7   
  1. Data are mean ± SD. HDL, high-density lipoprotein; LDL, low-density lipoprotein; Non-HDL, total cholesterol minus HDL; hs-CRP, high-sensitivity C-reactive protein. MIPS, multi-ingredient performance supplement. Placebo, carbohydrate placebo. Sample size between each analyte is slightly different due technical difficulties with certain samples.